当前位置：首页 > 文献互助 > 互助详情

Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort复制

用户EO9nReo4Hj6s 1小时前 7 10 已关闭

DOI:复制

文献链接:复制

其他信息:

上一篇：Loss of Payload Sensitivity and Other Mechanisms of Resistance to T-DXd in HER2-Mutant NSCLC: Implications for Subsequent Responsiveness to HER2 TKIs

下一篇：Trastuzumab Deruxtecan in Patients With HER2-Overexpressing NSCLC: Results From Part 1 of the Open-Label, Multicenter, Phase 1b DESTINY-Lung03 Trial

互助时间线

2026-04-30 18:22:46 [关闭求助]

楼主用户EO9nReo4Hj6s关闭了求助

2026-04-30 17:51:32 [发起求助]

最新发布的求助

Trastuzumab deruxtecan in HER2 overexpressing non-small cell lung cancer (NSCLC) 1小时前
Rhabdomyosarcoma spheroids with central proliferation and differentiation 1小时前
Trastuzumab Deruxtecan in Patients With HER2-Overexpressing NSCLC: Results From Part 1 of the Open-Label, Multicenter, Phase 1b DESTINY-Lung03 Trial 1小时前
Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort 1小时前
Loss of Payload Sensitivity and Other Mechanisms of Resistance to T-DXd in HER2-Mutant NSCLC: Implications for Subsequent Responsiveness to HER2 TKIs 1小时前
BPI26-027: Multidisciplinary Practice Patterns in HER2-Mutant NSCLC: Insights to Inform Precision Oncology Education 1小时前
ERBB2 activating mutations and co-occurring genomic alterations contribute to disease heterogeneity in patients with ERBB2-mutant lung cancer 1小时前
Decreased rat rhabdomyosarcoma pulmonary metastases in response to a low methionine diet 1小时前
A comparison of five transition programmes for youth with chronic illness in Canada 2小时前
Transition care for young people with chronic illness 2小时前
Transition Planning Among US Youth With and Without Special Health Care Needs 2小时前
Current Status of Transition Preparation Among Youth With Special Needs in the United States 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com